BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 91166)

  • 1. Definition of a unique cell surface antigen of mouse leukemia RL male 1 by cell-mediated cytotoxicity.
    Nakayama E; Shiku H; Takahashi T; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3486-90. PubMed ID: 91166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of a unique antigen on radiation leukemia virus-induced leukemia B6RV2.
    Nakayama E; Uenaka A; Stockert E; Obata Y
    Cancer Res; 1984 Nov; 44(11):5138-44. PubMed ID: 6091870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface antigens of murine leukemias induced by radiation leukemia virus. Recognition of individually distinct cell surface antigens by cytotoxic T cells on leukemias expressing crossreactive transplantation antigens.
    Morishita H; Shiku H; Horibe K; Obata Y; Stockert E; Oettgen HF; Old LJ; Yamada K
    J Exp Med; 1986 Feb; 163(2):452-7. PubMed ID: 3003228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
    Kaneko Y; Oettgen HF; Obata Y; Nakayama E
    Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of in vivo administration of Lyt antibodies. Lyt phenotype of T cells in lymphoid tissues and blocking of tumor rejection.
    Nakayama E; Uenaka A
    J Exp Med; 1985 Feb; 161(2):345-55. PubMed ID: 3871834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural occurrence of lymphocytes showing cytotoxic activity to BALB/c radiation-induced leukemia RL male 1 cells.
    Sendo F; Aoki T; Boyse EA; Buafo CK
    J Natl Cancer Inst; 1975 Sep; 55(3):603-9. PubMed ID: 1159837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of interleukin 2-dependent cytotoxic T-cell clones: specificity, cell surface phenotype, and susceptibility to blocking by Lyt antisera.
    Palladino MA; Obata Y; Stockert E; Oettgen HF
    Cancer Res; 1983 Feb; 43(2):572-6. PubMed ID: 6600215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.
    Keyaki A; Kuribayashi K; Sakaguchi S; Masuda T; Yamashita J; Handa H; Nakayama E
    Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.
    Kuribayashi K; Keyaki A; Sakaguchi S; Masuda T
    Immunology; 1985 Sep; 56(1):127-40. PubMed ID: 3876271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera.
    Nakayama E; Shiku H; Stockert E; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1977-81. PubMed ID: 88050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.
    Sato H; Boyse EA; Aoki T; Iritani C; Old LJ
    J Exp Med; 1973 Sep; 138(3):593-606. PubMed ID: 4727915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.
    Plata F; Tilkin AF; Lévy JP; Lilly F
    J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface antigens of chemically induced sarcomas of the mouse. I. Murine leukemia virus-related antigens and alloantigens on cultured fibroblasts and sarcoma cells: description of a unique antigen on BALB/c Meth A sarcoma.
    DeLeo AB; Shiku H; Takahashi T; John M; Old LJ
    J Exp Med; 1977 Sep; 146(3):720-34. PubMed ID: 197192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of CD8 T-cell response by IFNgamma ELISPOT and H-2L(d)/pRL1a tetramer assays in pRL1a multiple antigen peptide-immunized and RL male 1-bearing BALB/c and (BALB/c x C57BL/6) F(1) mice.
    Takada I; Noguchi Y; Kenjo A; Wada H; Uenaka A; Fujita T; Inoue H; Nakayama E
    Cancer Sci; 2004 Mar; 95(3):254-9. PubMed ID: 15016326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of multiple unique rejection antigens on murine leukemia BALB/c RLmale symbol1 and the role of dominant Akt antigen for tumor escape.
    Matsuo M; Wada H; Honda S; Tawara I; Uenaka A; Kanematsu T; Nakayama E
    J Immunol; 1999 Jun; 162(11):6420-5. PubMed ID: 10352255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.